Use of Pre-Assembled Plastic Microfluidic Chips for Compartmentalizing Primary Murine Neurons
November 2nd, 2018
54.4K views
This protocol describes the use of plastic chips to culture and compartmentalize primary murine neurons. These chips are preassembled, user-friendly, and compatible with high-resolution, live, and fluorescence imaging. This protocol describes how to plate rat hippocampal neurons within these chips and perform fluidic isolation, axotomy and immunostaining.
Overview
This protocol details the utilization of preassembled plastic microfluidic chips for the culture and compartmentalization of primary rat neurons. The chips facilitate high-resolution imaging and enable the study of axonal development, synaptic remodeling, and the dynamics of pathological propagation in neurons.
Key Study Components
Area of Science
- Neuroscience
- Cell Culture
- Neuronal Imaging
Background
- Microfluidic devices are standard tools for manipulating neurons at subcellular levels.
- The study focuses on the advantages of using plastic chips over silicon-based devices.
- The approach allows for healthier long-term growth of neurons.
- Human stem cells can also be cultured in the chips, enhancing their versatility.
Purpose of Study
- To describe a protocol for compartmentalizing culture primary rat neurons.
- To demonstrate a user-friendly method that supports high-resolution imaging.
- To shed light on neuron behavior in conditions such as axonal injury and synaptic dynamics.
Methods Used
- Microfluidic chips were used for the culture of primary rat hippocampal neurons.
- The model involved axonal isolation and processes such as axotomy and immunostaining.
- No multiomics workflows were discussed in the text.
- Detailed procedural steps for preparing the chip and neuronal media were outlined.
- Imaging was conducted to assess the neurons post-culture.
Main Results
- The protocol enables effective compartmentalization of neurons, leading to healthier neuron growth.
- Empirical observations of axonal behavior and responses to interventions can be quantified.
- The method provides insights into axonal injury responses and potential regeneration.
- Fluorescence imaging reveals detailed morphological changes in the neurons.
Conclusions
- The study establishes an effective methodology for neuron compartmentalization and assessment.
- Although no metabolic assessments were made, the findings enhance understanding of neuronal plasticity.
- The established protocol supports future investigations into neuronal mechanisms and disease models.
Frequently Asked Questions
What are the advantages of using plastic microfluidic chips?
Plastic chips are user-friendly, promote healthier neuron cultures, and are compatible with high-resolution microscopy.
How are primary rat neurons cultured in the chips?
Neurons are plated using a cell suspension in the designated wells of the chip, allowing for compartmentalized growth.
What types of data can be obtained through this method?
Outcomes include imaging data on neuronal morphology, axonal behavior under different conditions, and potential findings related to regeneration.
Can this method be applied to other cell types?
Yes, human stem cells can also be cultured within the microfluidic chips, broadening its application.
What are the limitations of this protocol?
Considerations may include the necessity for precise handling of the microfluidic devices and the potential challenges in maintaining sterility throughout the process.
Executive Industry Relevance
Pre-assembled plastic microfluidic chips enable robust compartmentalization of primary neurons, supporting high-resolution interrogation of axonal growth, synaptic remodeling, and injury response. This platform enhances predictive confidence in neuronal mechanism studies and facilitates translational continuity from discovery to preclinical neurobiology. The chip's reproducibility and compatibility with long-term cultures position it as a reusable asset for neuroscience-focused R&D portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables precise manipulation and isolation of neuronal subcellular compartments for mechanistic de-risking.
- Supports functional validation of neuronal targets by allowing controlled axotomy and synaptic marker analysis.
- Facilitates hypothesis-driven studies on axonal development and synaptic plasticity relevant to neurodegenerative disease models.
Screening & Assay Development
- Provides a standardized, reproducible system for preparing compartmentalized neuronal cultures suitable for quantitative imaging assays.
- Enables robust immunocytochemistry and live-cell imaging workflows for compound evaluation.
- Supports scalability and platform reuse across multiple neuronal and stem cell models.
Translational & Preclinical Research
- Aligns with disease-relevant systems by modeling axonal injury and regeneration in vitro.
- Enables continuity from discovery-stage mechanistic studies to preclinical validation of neuroprotective strategies.
- Supports risk-adjusted advancement decisions by providing quantitative, reproducible readouts of neuronal health and synaptic integrity.
Pipeline & Workflow Integration
This microfluidic chip platform integrates into the neuroscience discovery continuum, from early mechanistic studies through preclinical model development.
- Discovery Biology: Facilitates hypothesis testing on axonal growth, synaptic remodeling, and injury response in a controlled environment.
- Screening: Delivers assay-ready, compartmentalized cultures for reproducible imaging and immunostaining outputs.
- Analytics: Provides quantitative morphological and marker-based readouts for comparative analysis across experimental conditions.
- Translational Research: Models disease-relevant neuronal processes, supporting biomarker alignment and preclinical study design.
- Enterprise Reuse: Offers a standardized, scalable platform adaptable to various neuronal and stem cell systems.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in neuronal mechanism studies and target validation.
- Operational Value: Enhances reproducibility, standardization, and long-term culture viability.
- Strategic Value: Improves go/no-go decision-making and reduces late-stage biological risk in neurobiology pipelines.
- Portfolio Impact: Enables risk-adjusted prioritization of neurotherapeutic programs through robust, quantitative data.
Implementation Considerations
- Requires expertise in neuronal culture and microfluidic device handling.
- Demands access to high-resolution imaging and immunocytochemistry infrastructure.
- Necessitates cross-team standardization for reproducible compartmentalization and assay outputs.
- Adaptable to both rodent and human stem cell-derived neuronal models.
- Maintaining sterility and optimal culture conditions is critical for long-term viability.
Biopharma FAQs
Why does null hypothesis testing matter for axotomy-induced regeneration studies?
Null hypothesis testing in axotomy experiments enables objective assessment of whether observed axonal regeneration exceeds baseline variability, supporting rigorous target validation and mechanistic de-risking in neuronal repair research.
How does independent axonal compartment isolation fit the discovery pipeline?
Isolating axonal compartments allows researchers to manipulate and analyze axons separately from somata, clarifying pathway-specific effects and supporting early-stage mechanistic studies in neurobiology pipelines.
What do quantitative immunostaining measurements enable in neuronal cultures?
Quantitative immunostaining provides reproducible data on synaptic marker expression and axonal health, enabling comparative analysis across experimental conditions and supporting data-driven advancement decisions.
Why are replication requirements critical for cross-functional neuroscience teams?
Replication ensures that compartmentalized culture and injury-response findings are robust and transferable, facilitating collaboration between discovery, screening, and translational research teams.
What statistical analysis capabilities are required before implementing axotomy workflows?
Teams must establish quantitative endpoints and statistical methods for analyzing axonal regeneration and synaptic marker data to ensure reliable interpretation and portfolio-relevant decision-making.
Chapters in this video
0:04
Title
1:27
Preparation and Coating of the Multicompartment Chips
3:57
Seeding Neurons into the Multicompartment Chips
5:03
Fluidic Isolation of the Axonal Compartment within the Chip
5:49
Performing Axotomy Within the Chip
6:36
Fluorescence Immunostaining within the Chip
9:03
Results: Neuronal Growth Comparison within Multicompartment PDMS Devices and Plastic Chips
10:21
Conclusion
